Cargando…

Protective Effect of Neonatal Hepatitis B Vaccine Against HBV Breakthrough Infection in Children with Leukemia: A Real-world Study

BACKGROUND AND AIMS: Hepatitis B vaccine is the most effective preventive measure against hepatitis B virus (HBV) infection. However, the risk of HBV breakthrough infection in fully immunized children (neonatal hepatitis B immunization) who receive immunosuppressive therapy and transfusion of blood...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yuting, Xiao, Jianwen, Zhang, Xiuyu, Yang, Hui, Zhang, Zhenzhen, Xu, Hongmei, Huang, Ailong, Zhao, Yao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547253/ https://www.ncbi.nlm.nih.gov/pubmed/36304512 http://dx.doi.org/10.14218/JCTH.2021.00291

Ejemplares similares

Complementary Presence of HBV Humoral and T-cell Response Provides Protective Immunity after Neonatal Immunization
por: Huang, Yunmei, et al.
Publicado: (2022)

The prevalence of occult HBV infection in immunized children with HBsAg-positive parents: a hospital-based analysis
por: Zhuge, Shurui, et al.
Publicado: (2020)

Evaluation of the in situ assay for HBV DNA: An observational real-world study in chronic hepatitis B
por: Li, Chang, et al.
Publicado: (2021)

Nomogram Model for Prediction of SARS-CoV-2 Breakthrough Infection in Fujian: A Case–Control Real-World Study
por: Chen, Tianbin, et al.
Publicado: (2022)

On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis B
por: Huang, Yi-Jie, et al.
Publicado: (2017)

Deep Sequencing Analysis of HBV Genotype Shift and Correlation with Antiviral Efficiency during Adefovir Dipivoxil Therapy
por: Wang, Yuwei, et al.
Publicado: (2015)

Change of Cytokines in Chronic Hepatitis B Patients and HBeAg are Positively Correlated with HBV RNA, Based on Real-world Study
por: Zhang, Qiqi, et al.
Publicado: (2022)

Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice
por: Mo, Ying-Qian, et al.
Publicado: (2014)

The Infection Efficiency and Replication Ability of Circularized HBV DNA Optimized the Linear HBV DNA in Vitro and in Vivo
por: Li, Xiaosong, et al.
Publicado: (2015)

Breakthrough!: 100 astronomical images that changed the world
por: Gendler, Robert, et al.
Publicado: (2015)

CRISPR/Cas9 delivery by NIR-responsive biomimetic nanoparticles for targeted HBV therapy
por: Wang, Dan, et al.
Publicado: (2022)

Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
por: Uchiike, Akihiro, et al.
Publicado: (2023)

Molecular and Genetic Characterization of Hepatitis B Virus (HBV) among Saudi Chronically HBV-Infected Individuals
por: Di Stefano, Mariantonietta, et al.
Publicado: (2023)

Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection
por: Zhang, Lu, et al.
Publicado: (2023)

Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
por: Ho, Joan Kha-Tu, et al.
Publicado: (2020)

Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China
por: Yang, Shigui, et al.
Publicado: (2015)

Metabolic Regulation of Hepatitis B Virus Infection in HBV-Transgenic Mice
por: Lan, Wenning, et al.
Publicado: (2022)

Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis
por: Zhang, Yuan, et al.
Publicado: (2021)

Breakthroughs and challenges in the management of pediatric viral hepatitis
por: Nicastro, Emanuele, et al.
Publicado: (2021)

Performance Evaluation of the Beckman Coulter DxN VERIS Hepatitis B Virus (HBV) Assay in Comparison With the Abbott RealTime HBV Assay
por: Park, Joonhong, et al.
Publicado: (2019)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
por: Zheng, Ye, et al.
Publicado: (2022)

A Real-world Prospective Study of Mother-to-child Transmission of HBV in China Using a Mobile Health Application (Shield 01)
por: Yin, Xueru, et al.
Publicado: (2020)

Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction
por: Yang, Yinli, et al.
Publicado: (2017)

COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness
por: Reynolds, Matthew W, et al.
Publicado: (2022)

Pyruvate kinase activator: A major breakthrough in the world of Hematology
por: Iqbal, Amna, et al.
Publicado: (2022)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
por: Gozlan, Yael, et al.
Publicado: (2022)

Virological breakthrough after immune checkpoint inhibitor and nucleos(t)ide analog treatment in patients with hepatitis B surface antigen positive hepatocellular carcinoma: a real-world study
por: Wang, Kunyuan, et al.
Publicado: (2021)

Breakthroughs in hepatitis C research: from discovery to cure
por: Manns, Michael P., et al.
Publicado: (2022)

Evaluation of the Aptima HBV Quant Assay Compared to Abbott RealTime M2000 HBV Quant Assay and Procleix Ultrio Plus dHBV Assay in Plasma Samples
por: Yan, Ying, et al.
Publicado: (2022)

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
por: Lim, Young-Suk
Publicado: (2023)

COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness [Corrigendum]
Publicado: (2022)

Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma
por: Yang, Liu, et al.
Publicado: (2018)

DNA Immunization with Fusion of CTLA-4 to Hepatitis B Virus (HBV) Core Protein Enhanced Th2 Type Responses and Cleared HBV with an Accelerated Kinetic
por: Yin, Ying, et al.
Publicado: (2011)

Durability of Hepatitis B surface antigen seroclearance in patients experienced nucleoside analogs or interferon monotherapy: A real-world data from Electronic Health Record
por: Shi, Zongqi, et al.
Publicado: (2022)

Lamivudine treatment for severe acute HBV hepatitis
por: Lisotti, Andrea, et al.
Publicado: (2008)

Hepatitis Delta Virus: HDV-HBV Interactions
por: Sureau, Camille
Publicado: (2006)

Significance of bone marrow fibrosis in acute myeloid leukemia for survival in the real-world
por: Zhang, Xia, et al.
Publicado: (2022)

Pediatric non–Down’s syndrome acute megakaryoblastic leukemia patients in China: A single center's real-world analysis
por: Zhang, Aoli, et al.
Publicado: (2022)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

Breakthrough!
por: KURNIT, Paul
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_sef9amg1rpubhiavtshpodp1ra